EDAP TMS SA
(NASDAQ : EDAP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
ARRYArray BioPharma Inc.
0.08%46.468.1%$739.15m
AMGNAmgen Inc.
0.31%176.661.3%$505.14m
CELGCelgene Corporation
-0.01%91.751.3%$444.15m
GILDGilead Sciences, Inc.
-1.89%66.790.9%$403.73m
BIIBBiogen Inc.
-0.29%232.951.3%$386.56m
ILMNIllumina, Inc.
0.14%302.703.5%$336.23m
REGNRegeneron Pharmaceuticals, Inc.
-0.23%297.512.6%$277.51m
SRPTSarepta Therapeutics, Inc.
-2.61%152.8114.7%$203.41m
ALXNAlexion Pharmaceuticals, Inc.
0.55%123.712.0%$199.23m
VRTXVertex Pharmaceuticals Incorporated
0.04%176.441.9%$187.56m
EXASExact Sciences Corporation
-0.64%115.4524.1%$139.59m
AAgilent Technologies, Inc.
-0.89%69.921.6%$134.06m
INCYIncyte Corporation
-1.44%80.222.5%$114.43m
BLUEBluebird Bio, Inc.
-1.29%134.0014.3%$97.93m
BMRNBioMarin Pharmaceutical Inc.
-1.77%82.504.3%$87.77m

Company Profile

EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses in the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.